X4 Pharmaceuticals

XFOR

Börsenwert 317 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	2,91 Mio. $	–	–	–
2	TLP 2 Tri Locum Partners New York	1,68 Mio. $	+26.247 $	+690	+1 %
3	3 Ikarian Capital Dallas, Texas	1,62 Mio. $	+390.209 $	+10.258	+22 %
4	4 Point72 Asset Management Stamford, Connecticut	1,58 Mio. $	–	–	–
5	5 OrbiMed New York	1,33 Mio. $	–	–	–
6	6 Axa Paris, France	1,11 Mio. $	-1.103 $	-29	-0,1 %
7	ACM 7 AIGH Capital Management Baltimore, Maryland	962.000 $	–	–	–
8	8 BVF Inc San Francisco, California	818.000 $	–	–	–
9	9 Vanguard Group Malvern, Pennsylvania	690.000 $	+78.590 $	+2.066	+9 %
10	10 New Leaf Venture Partners New York	323.000 $	–	–	–
11	11 SV Health Investors Boston, Massachusetts	300.000 $	–	–	–
12	12 Worth Venture Partners Fort Lee, New Jersey	278.000 $	–	–	–
13	13 BlackRock New York	268.000 $	+7.151 $	+188	+2 %
14	14 Sio Capital Management New York	267.000 $	–	–	–
15	15 Renaissance Technologies New York	209.000 $	+54.625 $	+1.436	+25 %
16	16 Geode Capital Management Boston, Massachusetts	182.000 $	+7.950 $	+209	+3 %
17	17 Boothbay Fund Management New York	174.000 $	+49.451 $	+1.300	+28 %
18	18 Bank of New York Mellon New York	135.000 $	-1.141 $	-30	-0,6 %
19	19 Cormorant Asset Management Boston, Massachusetts	100.000 $	–	–	–
20	20 Millennium Management New York	75.000 $	-413.680 $	-10.875	-81 %
21	21 Stifel Financial St. Louis, Missouri	65.000 $	-2.701 $	-71	-3 %
22	22 Dimensional Fund Advisors Austin, Texas	59.000 $	–	–	–
23	23 Northern Trust Chicago, Illinois	54.000 $	+418 $	+11	+0,6 %
24	24 Minot Wealth Management Westwood, Massachusetts	53.000 $	–	–	–
25	25 State Street Boston, Massachusetts	53.000 $	–	–	–

X4 Pharmaceuticals XFOR Börsenwert 317 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 317 Mio. $